ClinicalTrialsFinder
RecruitingNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Sponsor

Sanguine Biosciences

Enrollment

20,000 participants

Start Date

Oct 26, 2021

Study Type

OBSERVATIONAL

Conditions

CancerLymphomaLeukemiaAsthmaCirrhosisMyasthenia GravisStrokeAmyloidosisCOPDBeta-ThalassemiaCystic FibrosisSickle Cell DiseaseDiabetesCeliac DiseaseMultiple SclerosisFibromyalgiaAge-Related Macular DegenerationAllergiesAlpha-Gal SyndromeAlzheimer DiseaseAnkylosing SpondylitisArthritisAlopecia AreataAtopic DermatitisAutismAutoimmune HepatitisBehcet's DiseaseKidney DiseasesCrohn DiseaseDravet SyndromeDMDGraves DiseaseThyroid DiseasesHepatitisHidradenitis SuppurativaITPALSLupus or SLEHeart DiseasesParkinson DiseasePemphigus VulgarisPsoriasisSchizophreniaSclerodermaUlcerative ColitisVasculitisVitiligo

Summary

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and develop new treatments, diagnostics, and preventative methods for specific and complex conditions.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This is a biospecimen repository study that collects blood, tissue, and other biological samples from volunteers — both healthy individuals and those with various health conditions — to support future medical research. It is not testing a treatment. **You may be eligible if...** - You are between 18 and 85 years old - You can understand and sign the informed consent form - You may have a specific health condition documented in your medical records, or be a healthy volunteer **You may NOT be eligible if...** - You cannot provide informed consent - You are outside the age range of 18–85 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSpecimen sample

The study may require a tissue collection and/or a participant survey for participation. Most tissue collected will come from a blood draw; up to 100mL for the health condition group, 60mL for the exceptive condition group, and up to 180mL for the control group (if determined safe for the participant). Participant surveys may involve participant reported outcomes (PROs) or custom participant surveys.

Locations(1)

Sanguine Biosciences

Waltham, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05635266

Related Trials

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

NCT055881411 location

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

NCT06307665135 locations

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

NCT0643908231 locations

Tumor Related Epilepsy

NCT026393251 location